2026

  1. Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial

  2. Ustekinumab for fistulising perianal Crohn’s disease: a randomised placebo-controlled trial from the GETAID

  3. Efficacy and safety of duvakitug in patients with Crohn’s disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

  4. Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

  5. Tasty&Healthy exclusive whole food diet in asymptomatic children and young adults with biologically active Crohn’s disease: the TASTI-E randomized controlled trial

  6. Resection of the mesentery vs Kono-S anastomosis in preventing surgical recurrence for primary Crohn disease: the REMEASURE prospective, randomized, controlled trial